Cancer

Cell culture and mouse studies suggest inhibiting the long non-coding RNA (lncRNA) ORILNC1 could help treat KRAS-driven breast cancer and BRAF-driven melanoma. In KRAS-mutant breast cancer and BRAF-mu...